Hydrolina Biotech Profile
Key Indicators
- Authorised Capital ₹ 5.00 Cr
as on 28-12-2024
- Paid Up Capital ₹ 4.11 Cr
as on 28-12-2024
- Company Age 25 Year, 5 Months
- Last Filing with ROC 31 Mar 2019
- Open Charges ₹ 4.58 Cr
as on 28-12-2024
- Satisfied Charges ₹ 7.15 Cr
as on 28-12-2024
- Revenue 10304.82%
(FY 2019)
- Profit 71.46%
(FY 2019)
- Ebitda -1141.69%
(FY 2019)
- Net Worth -34.35%
(FY 2019)
- Total Assets -17.88%
(FY 2019)
About Hydrolina Biotech
The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2019. It's a company limited by shares with an authorized capital of Rs 5.00 Cr and a paid-up capital of Rs 4.11 Cr.
The company currently has active open charges totaling ₹4.58 Cr. The company has closed loans amounting to ₹7.15 Cr, as per Ministry of Corporate Affairs (MCA) records.
Nunavath Yugandher and Gurudeep Sidhu serve as directors at the Company.
- CIN/LLPIN
U15440TN1999PTC042911
- Company No.
042911
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
23 Jul 1999
- Date of AGM
30 Sep 2019
- Date of Balance Sheet
31 Mar 2019
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Chennai, Tamil Nadu, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Hydrolina Biotech?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nunavath Yugandher  | Director | 23-Oct-2023 | Current |
| Gurudeep Sidhu | Director | 23-Oct-2023 | Current |
Financial Performance of Hydrolina Biotech.
Hydrolina Biotech Private Limited, for the financial year ended 2019, experienced significant growth in revenue, with a 10304.82% increase. The company also saw a substantial improvement in profitability, with a 71.46% increase in profit. The company's net worth observed a substantial decline by a decrease of 34.35%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Hydrolina Biotech?
In 2019, Hydrolina Biotech had a promoter holding of 98.58% and a public holding of 1.42%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Jetapex Mines And Minerals Private LimitedActive 2 years 7 monthsNunavath Yugandher is a mutual person
- Jetapex Paper Industries Private LimitedActive 4 years 6 months
Nunavath Yugandher is a mutual person
- Honey Bee Infra Developers Private LimitedActive 1 year 7 months
Nunavath Yugandher and Gurudeep Sidhu are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Department Of Biotechnology Creation Date: 13 Mar 2009 | ₹4.58 Cr | Open |
Others Creation Date: 18 Nov 2010 | ₹4.30 Cr | Satisfied |
Canara Bank Creation Date: 31 Jan 2003 | ₹2.85 Cr | Satisfied |
How Many Employees Work at Hydrolina Biotech?
Hydrolina Biotech has a workforce of 0 employees as of Mar 31, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Hydrolina Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Hydrolina Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
